- March 18, 2026Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and Manufacturing Organisation (CDMO), today announces…
- February 2, 2026Viral Vector Manufacturing Facility Pty Ltd (VVMF) announces its participation at Advanced Therapies Week 2026, 9 – 12 February 2026,…
- October 30, 2025Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and Manufacturing Organisation (CDMO), has commenced…
- October 28, 2025Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first and only clinical and commercial-scale viral vector Contract Development and Manufacturing…
- October 15, 2025Viral Vector Manufacturing Facility Pty Ltd (VVMF) and Chimeric Therapeutics (ASX:CHM, “Chimeric”) have cosigned a Letter of Intent (LOI) to…
- September 18, 2025Viral Vector Manufacturing Facility Pty Ltd (VVMF) announces its participation at the Cell & Gene Meeting on the Mesa 2025,…
- July 16, 2025Viral Vector Manufacturing Facility Pty. Ltd. (VVMF) and Cell Therapies Pty Ltd. have co-signed a memorandum of understanding (MoU) to…
- May 21, 2025Viral Vector Manufacturing Facility Pty Ltd (VVMF) announces its participation at the Bio International Conference 2025, June 16-19 2025, at…
- April 18, 2025Viral Vector Manufacturing Facility Pty Ltd (VVMF) is set to participate in BIO KOREA 2025, May 7-9 2025, bringing its…
- July 4, 2024The Viral Vector Manufacturing Facility Pty Ltd (VVMF) is delighted to announce the following appointments to the Board. Sue MacLeman:…